Product Owner, Clinical Trial Site Management

444397

At GSK, we have bold ambitions for patients, aiming to positively impact the health of 2.5 billion people by the end of the decade. Our R&D focuses on discovering and delivering vaccines and medicines, combining our understanding of the immune system with cutting-edge technology to transform people's lives. We're uniting science, technology, and talent to get ahead of disease together.

The Team

The Clinical Trial Site Management team owns the technology that enables how GSK engages, activates, and partners with clinical trial sites from feasibility and study start-up through trial execution and close-out. We build connected, scalable capabilities that accelerate trial delivery and improve the experience for our sites.

Clinical trial sites are partners and customers, not simply recipients of GSK processes and technology. The Product Owner ensures that site and operations-facing products - from externally used site tools through to internal operational systems like contracting and budgeting platforms are built and adopted in ways that deliver tangible value and impact.

The Role

The Product Owner is expected to lead with an AI-first mindset, applying AI as the default approach to discovery, analysis, decision-making, product design, and delivery. The role requires continuously challenging existing processes and assumptions, identifying opportunities where AI can simplify, automate, augment, or fundamentally transform how clinical trial sites and operational teams work. Reporting to the Senior Director, this role combines deep domain expertise with strong stakeholder leadership, financial accountability, and product management excellence.

Product Strategy & Delivery

• Own the product strategy, backlog, and delivery roadmap across your sub-portfolio of site and operations-facing processes, including feasibility, study start-up, contracting, budgeting, essential document collection, monitoring, etc.
• Partner with business stakeholders to drive prioritisation, investment decisions, and trade-offs, including financial oversight of your product portfolio.
• Use data, AI-driven insights, and performance metrics to identify opportunities, demonstrate value, inform decisions, and continuously optimise product outcomes.
• Represent your domain in portfolio-level planning and governance, ensuring technology priorities are well understood and supported at leadership level.
• Own product adoption and value realisation, ensuring capabilities are not only delivered but embedded into business processes but continuously improved

Stakeholder Partnership & Influence

• Partner closely with Development Operations to understand user needs, shape product direction, identify opportunities for process improvement and innovation, building a shared ownership of priorities and outcomes.
• Partner with DevTech CMO delivery teams and technology vendors to ensure increments are delivered to quality and on time, holding internal and external teams accountable for outcomes.
• Connect your sub-portfolio to the broader ecosystem of strategic Programmes, ensuring site management capabilities form a unified, data-centric digital landscape

AI-First Approach

• Apply AI as the default approach across all aspects of product management, using AI to accelerate discovery, analysis, prioritisation, design, delivery, testing, adoption, and measurement of value.
• Design products and capabilities that are AI-native where appropriate, leveraging conversational interfaces, intelligent agents, predictive insights, recommendations, and automation to improve user outcomes.
• Stay abreast of emerging AI technologies and industry trends, evaluating how new capabilities can be applied safely and effectively within GSK's clinical trial ecosystem.
• Drive responsible AI adoption, ensuring appropriate governance, validation, transparency, risk management, and regulatory compliance in a GxP environment.

Quality, Compliance & Governance

• Ensure product releases and process changes meet GxP compliance requirements and are supported by effective change management.
• Apply privacy, data, and AI governance principles from the outset, ensuring high-quality systems of record and timely management of risks and issues.

What You Bring

Basic Qualifications

We are looking for professionals with the following required skills and experience:

• Experience as a Product Owner or product leader in a complex, regulated environment, with a track record of independently owning vision, roadmap, and prioritisation at sub-portfolio or programme scale.
• Strong understanding of study start-up, site management, or related clinical trial operational processes, including internal operational tools and platforms.
• Demonstrated ability to lead through influence rather than authority, bringing together business, technology and vendor partners to deliver transformational outcomes.
• Clear communicator who can operate credibly across operational, strategic, and technical audiences, bridging the language of technology and business effectively.
• Track record of using data to drive decisions and demonstrate outcomes.
• Familiarity with GxP compliance requirements and regulated product delivery.
• Demonstrated ability to apply AI tools and technologies to improve product management effectiveness, accelerate delivery, and drive business outcomes.
• Experience identifying and delivering opportunities where AI transformed processes, products, or user experiences rather than simply automating existing activities.

Preferred Qualifications

• Hands-on experience with platforms such as Veeva or equivalent clinical trial site management or contracting tools.
• Experience with AI or ML solutions in regulated environments, including associated validation and governance requirements.
• Comfort operating in ambiguity, shaping strategy and requirements where direction is emerging rather than fully defined.

Closing date for applications: 26th July 2026.

Why GSK?

Uniting science, technology and talent to get ahead of disease together.

GSK is a global biopharma company with a purpose to unite science, technology and talent to get ahead of disease together. We aim to positively impact the health of 2.5 billion people by the end of the decade, as a successful, growing company where people can thrive. We get ahead of disease by preventing and treating it with innovation in specialty medicines and vaccines. We focus on four therapeutic areas: respiratory, immunology and inflammation; oncology; HIV; and infectious diseases - to impact health at scale.

People and patients around the world count on the medicines and vaccines we make, so...